Autoimmune response to advanced glycosylation end-products of human LDL
Open Access
- 1 March 2003
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 44 (3), 487-493
- https://doi.org/10.1194/jlr.m200370-jlr200
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation ReactionsJournal of Biological Chemistry, 1996
- Modification of Lipoproteins in DiabetesDiabetes/Metabolism Research and Reviews, 1996
- Activation of Human Monocyte-Derived Macrophages by Immune Complexes Containing Low-Density LipoproteinClinical Immunology and Immunopathology, 1995
- Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.JCI Insight, 1993
- Erythrocyte-bound low-density lipoprotein immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophagesClinical Immunology and Immunopathology, 1991
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetesBiochemical and Biophysical Research Communications, 1990
- Accumulation of cholesteryl esters in macrophages incubated with human lipoprotein-antibody autoimmune complexAtherosclerosis, 1988
- Demonstration of immunoglobulin in the neighbourhood of advanced atherosclerotic plaquesAtherosclerosis, 1980